Preoperative Breast Magnetic Resonance Imaging: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline
Open Access
- 30 June 2023
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 30 (7) , 6255-6270
Abstract
Background: The use of preoperative breast magnetic resonance imaging (MRI) after the diagnosis of breast cancer by mammography and/or ultrasound is inconsistent. Methods: After conducting a systematic review and meta-analysis comparing preoperative breast MRI versus no MRI, we reconvened to prepare a clinical practice guideline on this topic. Results: Based on the evidence that MRI improved recurrence, decreased the rates of reoperations (re-excisions or conversion mastectomy), and increased detection of synchronous contralateral breast cancer, we recommend that preoperative breast MRI should be considered on a case-by-case basis in patients diagnosed with breast cancer for whom additional information about disease extent could influence treatment. Based on stronger evidence, preoperative breast MRI is recommended in patients diagnosed with invasive lobular carcinoma for whom additional information about disease extent could influence treatment. For both recommendations, the decision to proceed with MRI would be conditional on shared decision-making between care providers and the patient, taking into account the benefits and risks of MRI as well as patient preferences. Based on the opinion of the Working Group, preoperative breast MRI is also recommended in the following more specific situations: (a) to aid in surgical planning of breast conserving surgery in patients with suspected or known multicentric or multifocal disease; (b) to identify additional lesions in patients with dense breasts; (c) to determine the presence of pectoralis major muscle/chest wall invasion in patients with posteriorly located tumours or when invasion of the pectoralis major muscle or chest wall is suspected; (d) to aid in surgical planning for skin/nipple-sparing mastectomies, autologous reconstruction, oncoplastic surgery, and breast conserving surgery with suspected nipple/areolar involvement; and (e) in patients with familial/hereditary breast cancer but who have not had recent breast MRI as part of screening or diagnosis.Keywords
Funding Information
- Ontario Ministry of Health
This publication has 74 references indexed in Scilit:
- Improvement in DCIS Detection Rates by MRI Over Time in a High-Risk Breast Screening StudyThe Breast Journal, 2011
- Frequency of Malignancy Seen in Probably Benign Lesions at Contrast-enhanced Breast MR Imaging: Findings from ACRIN 6667Radiology, 2010
- Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working groupEuropean Journal of Cancer, 2010
- Reasons Women at Elevated Risk of Breast Cancer Refuse Breast MR Imaging Screening: ACRIN 6666Radiology, 2010
- Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical ManagementJournal of Clinical Oncology, 2009
- Breast MRI: guidelines from the European Society of Breast ImagingEuropean Radiology, 2008
- MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast CancerNew England Journal of Medicine, 2007
- MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literatureBreast Cancer Research and Treatment, 2007
- Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006European Journal of Cancer, 2007
- Mammographic detection and staging of invasive lobular carcinomaClinical Imaging, 2005